Old Web
English
Sign In
Acemap
>
authorDetail
>
Colleen Watt
Colleen Watt
Alliance for Clinical Trials in Oncology
Oncology
Internal medicine
Medicine
VEGF receptors
Cell
2
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CASPAR (Alliance A031902): A randomized, phase III trial of enzalutamide (ENZ) with rucaparib (RUCA)/placebo (PBO) as a novel therapy in first-line metastatic castration-resistant prostate cancer (mCRPC).
2021
Journal of Clinical Oncology
Arpit Rao
Charles J. Ryan
David J. VanderWeele
Glenn Heller
Lionel D. Lewis
Colleen Watt
Ronald C. Chen
Robert L. Grubb
Olwen Hahn
Himisha Beltran
Michael J. Morris
Show All
Source
Cite
Save
Citations (2)
PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).
2019
Journal of Clinical Oncology
Tian Zhang
Karla V. Ballman
Atish D. Choudhury
Ronald C. Chen
Colleen Watt
Yujia Wen
Tyler Zemla
Hamid Emamekhoo
Ulka N. Vaishampayan
Michael J. Morris
Daniel J. George
Toni K. Choueiri
Show All
Source
Cite
Save
Citations (6)
1